Novo Nordisk (NYSE:NVO)

Top Analyst Upgrades and Downgrades: Apple, Baker Hughes, Conagra, Facebook, GE, Halliburton, Petrobras, Schlumberger, Vodafone, Walmart and More

Stocks were looking to open lower on Monday, but it was expected to be a fairly quiet day with the Columbus Day holiday keeping part of the banking system closed. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BioCryst, Exxon, FCA, HPE, IAMGOLD, Mallinckrodt, Rockwell Collins and More

Stocks were indicated to open higher on Wednesday after Tuesday's strong sell-off. The indexes still remain close to all-time highs, and the one trend that has prevailed for more than ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AECOM, Apache, Panera, Sunoco, Wal-Mart and Many More

Stocks were indicated to open lower after a weaker than expected payrolls report on Friday. The bull market is now more than eight years old, but investors have shown over ...
Read Full Story »
Unhealthy Person

3 Sleeper Biotechs That Could Bounce Back Strong in 2017

When traders look at a stock at its highs and imagine what would be had they gotten in at the lows, the thought that invariably gets triggered is “At the ...
Read Full Story »
Stock Price

AstraZeneca, Novartis Drop into Tuesday’s 52-Week Low Club

November 22, 2016: Here are four stocks trading with relatively heavy volume among 38 equities making new 52-week lows in Tuesday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »
Stock Price

Pilgrim’s Pride, Sunoco Slide into Monday’s 52-Week Low Club

November 18, 2016: Here are four stocks trading with relatively heavy volume among 39 equities making new 52-week lows in Monday's session. On the NYSE, advancers led decliners by nearly ...
Read Full Story »
Stock Price

Infosys, Nielsen Dip into Friday’s 52-Week Low Club

November 18, 2016: Here are four stocks trading with relatively heavy volume among 46 equities making new 52-week lows in Friday's session. On the NYSE, advancers and decliners traded about ...
Read Full Story »
investing

Hedge Funds Bought Apple, P&G in Q3; Dumped Allergan, Charter

Building on a turn toward more equity investments in the second quarter of this year, the top 50 hedge funds boosted their equity positions by 2.9% in the third quarter. ...
Read Full Story »
Stock Price

Concordia, Vodafone in Monday’s 52-Week Low Club

November 7, 2016: Here are four stocks trading with relatively heavy volume among 106 equities making new 52-week lows in Monday's session. On the NYSE, advancers led decliners by nearly ...
Read Full Story »
Stock Price

Bristol-Myers, Staples Fall Into Monday’s 52-Week Low Club

October 7, 2016: Here are four stocks trading with relatively heavy volume among 26 equities making new 52-week lows in Monday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »
Stock Price

Kroger, Oil Tanker Firm Sail into Tuesday’s 52-Week Low Club

September 27, 2016: Here are four stocks trading with relatively heavy volume among 43 equities making new 52-week lows in Tuesday's session. NYSE advancers led decliners by nearly 3 to 2 ...
Read Full Story »
clinical trials

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward. One key analyst issued a few of its top picks ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Chesapeake Energy, JPMorgan, Melco Crown, Navistar, Randgold, Silver Wheaton, Verifone and More

Stocks were weak on Friday after closing lower on Thursday's post-ECB let-down. Even if valuations are high and even if the Federal Reserve keeps jawboning about raising interest rates, what ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva, Verifone and More

Stocks were looking down marginally ahead of the key Labor Department payrolls report, and then the markets went slightly positive after the 151,000 nonfarm payrolls report was positive but not ...
Read Full Story »
analysis

Sanofi Just Can’t Catch a Break, Knocking at Major Support Again

Investor sentiment surrounding French pharma giant Sanofi S.A. (NYSE: SNY) continues to sour after a string of disappointing news in recent months has brought its shares down below the key ...
Read Full Story »